Terason, manufacturer of Laptop Ultrasound imaging systems, has reached an agreement with SenoRx Inc to provide its Terason t3000 ultrasound for the launch of an additional model of the SenoSonix System.
An integration of SenoRx’s EnCor breast biopsy system with ultrasound imaging, the new version of the device incorporates a microminiaturization ultrasound technology that combines personal computing power and flexibility designed, developed and marketed by Terason.
The partners sat the versatile ultrasound technology, combined with SenoRx’s proprietary EnCor vacuum-assisted biopsy technology, results in an attractive alternative model of the SenoSonix System for customers. The modular design and sophisticated imaging architecture are now available in a reduced footprint with increased portability.
The original SenoSonix System received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October 2007.
According to Lloyd Malchow, SenoRx president and chief executive, the new SenoSonix model meets the needs of breast surgeons performing breast biopsy procedures with ultrasound in both their offices and in the hospital surgery suite. These users seek to have the flexibility of moving the ultrasound component between the two locations, which the product allows for. “The new system may be particularly well suited for markets in Europe and Asia where a significant percentage of biopsy procedures are performed utilizing ultrasound,” Malchow said. “We will begin introducing this product in the U.S. and in select countries in which we have launched the EnCor breast biopsy system.”
